FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Allergenic Panel Meeting Canceled

[ Price : $8.95]

Federal Register notice: FDA cancels a 5/15 Advisory Committee meeting due to outstanding review issues related to the safety and ...

Modified Device Consensus Standards Listing

[ Price : $8.95]

Federal Register notice: FDA modifies the list of standards it recognizes for use in medical device premarket reviews.

FAQ on 3D Printing of Medical Devices

[ Price : $8.95]

FDA posts Frequently Asked Questions on 3D Printing of Medical Devices, Accessories, Components, and Parts During the Covid-19 Pan...

FDA Nixes Trump Again on Chloroquine Use

[ Price : $8.95]

Despite repeated urging from president Trump to use the malaria drug chloroquine to treat coronavirus patients, FDA reiterates tha...

6 Observations on Innovative Compounding FDA-483

[ Price : $8.95]

FDA releases the FDA-483 with six observations from a 2017 inspection at Innovative Compounding Pharmacy.

FDA Emergency Use Authorization for Ventilators

[ Price : $8.95]

FDA issues an emergency use authorization for ventilators, anesthesia gas machines modified for use as ventilators, and positive p...

Teva Says Copaxone Should Have a BLA

[ Price : $8.95]

Teva sues FDA to force it to transition the NDA for Copaxone to a BLA as required under the Biologics Price Competition and Innova...

Innocoll NDA Resubmitted for Pain Product

[ Price : $8.95]

FDA accepts an Innocoll Holdings NDA resubmission for post-surgical pain product Xaracoll (bupivacaine hydrochloride collagen-matr...

FDA OKs Xellia Pharma Cleveland Sterile Drug Plant

[ Price : $8.95]

FDA approves Xellia Pharmaceuticals Cleveland, OH manufacturing site to make anti-infective drug products for the U.S. market.

FDA Approves BMS Zeposia for Relapsing MS

[ Price : $8.95]

FDA approves Bristol-Myers Squibbs Zeposia, a new oral treatment for relapsing multiple sclerosis.